Decreased expression of E6-associated protein in breast and prostate carcinomas

被引:36
作者
Gao, XH
Mohsin, SK
Gatalica, Z
Fu, GL
Sharma, P
Nawaz, Z
机构
[1] Creighton Univ, Ctr Canc, Omaha, NE 68178 USA
[2] Baylor Coll Med, Breast Ctr, Houston, TX 77030 USA
[3] Creighton Univ, Med Ctr, Dept Pathol, Omaha, NE 68131 USA
关键词
D O I
10.1210/en.2004-1198
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The E6-associated protein (E6-AP) is a dual function protein. It acts as an E3 ubiquitin-protein ligase as well as a steroid hormone receptor coactivator. Considering the influence of steroid hormone receptors and their coactivators in the normal development and tumorigenesis of reproductive organs of both genders, we examined the roles of E6-AP in the tumorigenesis of breast and prostate tissues. We demonstrated that the expression of E6-AP protein is decreased in human invasive breast and prostate carcinomas compared with their adjacent normal tissues, and this down-regulation of E6-AP is accompanied by the up-regulation of estrogen receptor ( ER)-alpha in breast and androgen receptor (AR) in prostate carcinomas. Furthermore, our in vivo data from E6-AP-knockout animals indicated that the expression levels of ER alpha and AR are increased in E6-AP-null mammary and prostate glands, respectively, when compared with that of normal control animals, suggesting that E6-AP modulates the protein levels of ER alpha in breast and AR in prostate glands.
引用
收藏
页码:1707 / 1712
页数:6
相关论文
共 26 条
[1]   Progesterone receptors - animal models and cell signaling in breast cancer - The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis [J].
Anderson, E .
BREAST CANCER RESEARCH, 2002, 4 (05) :197-201
[2]   AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].
Anzick, SL ;
Kononen, J ;
Walker, RL ;
Azorsa, DO ;
Tanner, MM ;
Guan, XY ;
Sauter, G ;
Kallioniemi, OP ;
Trent, JM ;
Meltzer, PS .
SCIENCE, 1997, 277 (5328) :965-968
[3]  
Bautista S, 1998, CLIN CANCER RES, V4, P2925
[4]   Mammary Gland Development and Tumorigenesis in Estrogen Receptor Knockout Mice [J].
Bocchinfuso, Wayne P. ;
Korach, Kenneth S. .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1997, 2 (04) :323-334
[5]   Androgen receptors in prostate cancer [J].
Culig, Z ;
Klocker, H ;
Bartsch, G ;
Hobisch, A .
ENDOCRINE-RELATED CANCER, 2002, 9 (03) :155-170
[6]   Different expression of androgen receptor coactivators in human prostate [J].
Fujimoto, N ;
Mizokami, A ;
Harada, S ;
Matsumoto, T .
UROLOGY, 2001, 58 (02) :289-294
[7]   Molecular biology of the androgen receptor [J].
Gelmann, EP .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (13) :3001-3015
[8]   Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer [J].
Gnanapragasam, VJ ;
Leung, HY ;
Pulimood, AS ;
Neal, DE ;
Robson, CN .
BRITISH JOURNAL OF CANCER, 2001, 85 (12) :1928-1936
[9]   Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status [J].
Hong, H ;
Kao, CH ;
Jeng, MH ;
Eble, JN ;
Koch, MO ;
Gardner, TA ;
Zhang, SB ;
Li, L ;
Pan, CX ;
Hu, ZQ ;
MacLennan, GT ;
Cheng, L .
CANCER, 2004, 101 (01) :83-89
[10]   Mutation of the angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation [J].
Jiang, YH ;
Armstrong, D ;
Albrecht, U ;
Atkins, CM ;
Noebels, JL ;
Eichele, G ;
Sweatt, JD ;
Beaudet, AL .
NEURON, 1998, 21 (04) :799-811